calpain inhibitor 2 has been researched along with fluorescein-5-isothiocyanate in 1 studies
| Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
|---|---|---|---|---|---|
| 68 | 0 | 13 | 8,493 | 33 | 2,090 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uckun, FM; Zhu, DM | 1 |
1 other study(ies) available for calpain inhibitor 2 and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells.
Topics: Agammaglobulinaemia Tyrosine Kinase; Apoptosis; Caspases; Cell Separation; DNA; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescein-5-isothiocyanate; HeLa Cells; HL-60 Cells; Humans; Immunoglobulin G; In Situ Nick-End Labeling; Jurkat Cells; K562 Cells; Lymphoma, Non-Hodgkin; Microscopy, Confocal; Oligopeptides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; src-Family Kinases; Time Factors; Tumor Cells, Cultured; U937 Cells | 2000 |